Skip to main content
News & Events

Genesis Research Group attends ISPOR 2025 in Montreal and asks ‘Is the IRA America’s HTA?’ View our schedule.

ISPOR schedule for Genesis Research Group

Genesis Research Group is attending ISPOR in Montreal from 14-16 May and taking part in multiple thought leadership sessions, including an HEOR Theater. You can find them at Booth 1306.

All industry professionals are warmly invited to visit their booth, pick up a complimentary custom-designed minifigure, explore Genesis Research Group solutions, and explore their latest scientific presentations and posters (details above).

Their strategic, scientific, and BD teams will be available throughout the event, so get in touch to book a meeting now to find out how Genesis’s agile, tech-enabled market access, HEOR, and real-world evidence partnerships can support your projects, or email solutions@genesisrg.com to request further information.

HEOR THEATER
Is IRA becoming America’s HTA?

The IRA Medicare drug price negotiation program introduces a negotiation mechanism for US drug pricing with HTA-like features. This raises the question of whether IRA is a de-facto HTA body – requiring clinical, economic, and RWE in a manner reminiscent of established HTA systems, and potentially shortening the profitable lifecycle for branded products.

Taking place at 11:45 – 12:15, Thursday 15 May, the presentation will be delivered by Priti Jhingran, PhD, and Adam Weston, Genesis Research Group, London, United Kingdom.

GENESIS RESEARCH GROUP RECEPTION
Visit Booth 1306 from 5-6pm on Wednesday 14th May to meet with our team

Enjoy complimentary drinks and bites and connect with the Genesis Research Group team at a drinks reception on ISPOR’s opening day.

You can book at meeting with Genesis Research Group at ISPOR by emailing solutions@genesisrg.com.

 

Headquarters:

HOBOKEN
111 River Street, Suite 1120
Hoboken, New Jersey 07030, US